Patents Assigned to Pulmonx, Inc.
  • Publication number: 20130338524
    Abstract: Lung conditions are diagnosed and optionally treated using a functional assessment catheter or a functional lung assessment and treatment catheter. A flow restrictive component is initially placed in a bronchus or lung passageway upstream from a diseased lung region. The isolated lung region is then functionally assessed through the catheter, while the flow restrictive component remains in place. If the patient is a good candidate for treatment by occlusive or restrictive treatment techniques, the flow resistive component may be left in place. If the patient is not suitable for such treatment, the flow resistive component may be removed.
    Type: Application
    Filed: November 29, 2012
    Publication date: December 19, 2013
    Applicant: Pulmonx, Inc.
    Inventors: Ajit Nair, Son Gia, Roger Farhnoltz, Nikolai Aljuri
  • Publication number: 20130023919
    Abstract: Devices, methods, and systems are provided for loading an implantable device into a container. One aspect of the loading system contains a loader element with a loading tunnel that is configured to gradually contract an implantable device into a compressed state of reduced size relative to an expanded state as the implantable device travels through the loading tunnel.
    Type: Application
    Filed: September 24, 2012
    Publication date: January 24, 2013
    Applicant: Pulmonx, Inc.
    Inventors: Ryan Olivera, Hoang Nguyen
  • Publication number: 20090241964
    Abstract: The volume of a hyperinflated lung compartment is reduced by sealing a distal end of the catheter in an airway feeding the lung compartment. Air passes out of the lung compartment through a passage in the catheter while the patient exhales. A one-way flow element associated with the catheter prevents air from re-entering the lung compartment as the patient inhales. Over time, the pressure of regions surrounding the lung compartment cause it to collapse as the volume of air diminishes. Residual volume reduction effectively results in functional lung volume expansion. Optionally, the lung compartment may be sealed in order to permanently prevent air from re-entering the lung compartment. The invention further discloses a catheter with a transparent occlusion element at its tip that enables examination of the lung passageway through a viewing scope.
    Type: Application
    Filed: March 19, 2009
    Publication date: October 1, 2009
    Applicant: Pulmonx, Inc.
    Inventors: Nikolai Aljuri, Rodney C. Perkins, Ryan Olivera, Hoang Nguyen, Sri Radhakrishnan, Niyazi Beyhan
  • Patent number: 6527761
    Abstract: Methods, systems, devices and kits for performing lung volume reduction in patients suffering from chronic obstructive pulmonary disease or other conditions using and comprising minimally invasive instruments introduced through the mouth (endotracheally) to isolate a target lung tissue segment from other regions of the lung and reduce lung volume. Isolation is achieved by deploying an obstructive device in a lung passageway leading to the target lung tissue segment. Once the obstructive device is anchored in place, the segment can be aspirated through the device. This may be achieved by a number of methods, including coupling an aspiration catheter to an inlet port on the obstruction device and aspirating through the port. Or, providing the port with a valve which allows outflow of gas from the isolated lung tissue segment during expiration of the respiratory cycle but prevents inflow of air during inspiration. In addition, a number of other methods may be used.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: March 4, 2003
    Assignee: Pulmonx, Inc.
    Inventors: Peter P. Soltesz, Robert Kotmel, Tony Wondka, Michael P. Reilly, Wally S. Buch